Document and Entity Information
Document and Entity Information | Nov. 30, 2023 |
Cover [Abstract] | |
Security Exchange Name | NASDAQ |
Amendment Flag | false |
Entity Central Index Key | 0001404644 |
Document Type | 8-K |
Document Period End Date | Nov. 30, 2023 |
Entity Registrant Name | Neoleukin Therapeutics, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-36327 |
Entity Tax Identification Number | 98-0542593 |
Entity Address, Address Line One | 188 East Blaine Street |
Entity Address, Address Line Two | Suite 450 |
Entity Address, City or Town | Seattle |
Entity Address, State or Province | WA |
Entity Address, Postal Zip Code | 98102 |
City Area Code | (866) |
Local Phone Number | 245-0312 |
Written Communications | true |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.000001 par value |
Trading Symbol | NLTX |
Entity Emerging Growth Company | false |